Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

830.9500 -0.55 (-0.07%)

NSE Aug 12, 2025 15:31 PM

98.93% Gain from 52W Low

Volume: 1.9M

Laurus Labs Ltd.

29 Jan 2022

830.95

-0.07%

Laurus Labs (HOLD): PAT declines 44% on negative operating leverage

Hold: Laurus Labs Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Inventory destocking in ARV API/FDF led to 20% YoY decline in revenue; guided to normalise from Q4

Number of FII/FPI investors increased from 259 to 293 in Jun 2025 qtr.